Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:876-881
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeymer, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeymer, U.

CLINICAL STUDIES

Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement

Uwe Zeymer, MD*, Karl-Ludwig Neuhaus, MD*, Karl Wegscheider, PhDa, Ulrich Tebbe, MD{dagger}, Peter Molhoek, MD{ddagger}, Rolf Schröder, MD, FACCa for the HIT-4 Trial Group1

a Coordinating Centers of the HIT-4 Trial, Kassel and Berlin, Germany
* Städtische Kliniken, Kassel, Germany
{dagger} Klinikum Lippe-Detmold, Detmold, Germany
{ddagger} Medisch Spectrum Twente, Enschede, The Netherlands

Manuscript received January 20, 1998; revised manuscript received May 11, 1998, accepted June 17, 1998.

Address for correspondence: Dr. Rolf Schröder, Universitätsklinikum Benjamin Franklin, Free University Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany

Objectives. This study assessed the prognostic impact of right ventricular involvement (RVI) in streptokinase-treated patients with inferior acute myocardial infarction (AMI) stratified for small or large AMI.

Background. Only scant data exist from small studies about the impact of reperfusion therapy on survival in patients with RVI during inferior AMI.

Methods. Right ventricular involvement was assessed by ST-segment elevation ≥0.1 mV in lead V4R and infarct size by the extent of ST-segment deviation on the baseline electrocardiogram: small AMI = sum ST-segment elevation ≤0.8 mV and no precordial ST-segment depression (small ST); large AMI = presence of precordial ST-segment depression or sum ST-segment elevation >0.8 mV (large ST) in 522 inferior AMI patients of the Hirudin for Improvement of Thrombolysis (HIT-4) Trial. In 187 patients, 90-min coronary angiography was performed.

Results. Right ventricular involvement was present in 169 patients (32%). Higher 30-day cardiac mortality rates with RVI (5.9% vs. 2.5%) were related to larger infarct size rather than to RVI. For large ST, a proximal right coronary artery lesion was observed in 52% with and in 23% without RVI. Patency rates at 90 min were similar (54% vs. 52%). In the 28% of patients who had small ST, cardiac mortality was less than 1% irrespective of the presence of RVI. Coronary artery lesions were mostly located distally. Patency rates were 27% with and 80% without RVI.

Conclusions. ST-segment elevation of ≥0.1 mV in V4R in inferior AMI patients is associated with larger infarct size and higher 30-day mortality rates. Right ventricular involvement is not an independent predictor of survival. In patients with small ST, cardiac mortality is low, even if ST V4R is ≥0.1 mV.

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  CK = creatine kinase
  ECG = electrocardiogram
  HIT = Hirudin for Improvement of Thrombolysis
  large ST = Presence of precordial ST-segment depression or ST-segment elevation >0.8 mV
  small ST = ST-segment elevation ≤0.8 mV and no precordial ST-segment depression
  RVI = right ventricular involvement




This article has been cited by other articles:


Home page
Eur Heart JHome page
Authors/Task Force Members, F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, et al.
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:
Eur. Heart J., December 1, 2008; 29(23): 2909 - 2945.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. A. Goldstein
Right versus left ventricular shock: A tale of two ventricles
J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1280 - 1282.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. A. Goldstein
Pathophysiology and management of right heart ischemia
J. Am. Coll. Cardiol., September 4, 2002; 40(5): 841 - 853.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Mehta, J. W. Eikelboom, M. K. Natarajan, R. Diaz, C. Yi, R. J. Gibbons, and S. Yusuf
Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. J.J. Wellens
The Value of the Right Precordial Leads of the Electrocardiogram
N. Engl. J. Med., February 4, 1999; 340(5): 381 - 383.
[Full Text]


Home page
JWatch Emergency Med.Home page
Predictive Value of Right Ventricular Infarction in Inferior AMI
Journal Watch Emergency Medicine, December 1, 1998; 1998(1201): 10 - 10.
[Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement